Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma × Acupuncture Therapy × Clear all

Phase

Status

Completed 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Supportive Care 1 Sepsis 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Pain 1 Menstruation Disturbances 1 Lymphoma 1 Lung Neoplasms 1 Insulin Resistance 1 Hyperandrogenism 1 Hot Flashes 1 Breast Neoplasms 1 Anxiety Disorders 1 Anatomic Stage I Breast Cancer AJCC v8 1 Agnosia 1

Interventions

Cyclophosphamide 27 fludarabine 18 Rituximab 16 obinutuzumab 11 venetoclax 9 Lenalidomide 9 Bendamustine Hydrochloride 9 Prednisone 7 zanubrutinib 5 pembrolizumab 5 ibrutinib 5 Exercise 5 Etoposide 5 Doxorubicin 5 Blood Specimen Collection 5 Biopsy 5 fludarabine phosphate 4 Vincristine 4 Mesna 4 Cytarabine 4 tafasitamab 3 loncastuximab tesirine 3 glofitamab 3 axicabtagene ciloleucel 3 acalabrutinib 3 Trimethoprim, Sulfamethoxazole Drug Combination 3 Temozolomide 3 Surveys and Questionnaires 3 Radiotherapy 3 Palliative Care 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05982223 2023-08-08

Integrative Medicine in Lymphoma Survivors

Bnai Zion Medical Center

Phase NA Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡